lpcn stock forecast zacks

Get the latest Lipocine Inc LPCN detailed stock quotes stock data Real-Time ECN charts stats and more. Real-time trade and investing ideas on Lipocine Inc LPCN from the largest community of traders and investors.

Lpcn Liver Biopsy Results

Rooms Rankings Earnings Newsletters Shop.

. The lowest target is 202 and the highest is. What are analysts forecasts for LPCN stock. Based on short-term price targets offered by three analysts the average price target for Lipocine comes to 333.

On March 9 th Lipocine reported its 2021 financial results generating 161 million in revenues driven predominantly by proceeds from its agreement with Antares for TLANDO. According to 8 stock analysts the average 12-month stock price forecast for Lipocine stock is 34 which predicts an increase of 65556. LPCN stock returns are.

Licensed by Zacks Investment. By John Vandermosten CFA NASDAQLPCN READ THE FULL LPCN RESEARCH REPORT NASH Open Label Extension Study Results On May 12 2022 Lipocine. NASDAQLPCN Get Rating Stock analysts at Zacks Small Cap lifted their FY2022 earnings per share estimates for shares of Lipocine in a research report issued to.

The forecasts range from a low of 200 to a high of 550. Price Target.

Lipocine Imminent Catalysts In Nash And Oral Testosterone Replacement Therapy Make For A Strong Buy Nasdaq Lpcn Seeking Alpha